Search

everythinglearnresearchcommunity

for

Search:↓

SIM01 significantly reduced post-COVID symptoms and is safe.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

During the COVID-19 pandemic, some skin conditions became more common while others decreased.

Cepharanthine has many medicinal uses but needs improvement for better effectiveness.

In Poland, people search more for certain skin conditions depending on the season, and despite more STD infections, searches for them have decreased, suggesting a need for better sexual education.

Synthetic antioxidants are effective, cheap, and stable, with some like zinc and cholecalciferol reducing child and cancer deaths, but the safety of additives like BHA, BHT, TBHQ, and PEG needs more research.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

Non-coding RNAs are important for hair growth and could lead to new hair loss treatments, but more research is needed.

Some COVID-19 patients have skin issues, with men, ICU patients, and those on multiple antibiotics at higher death risk; in-person skin checks by dermatologists are more effective.

Natural compounds, especially Withaferin-A, may help treat post-COVID-19 complications, but some may have side effects.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

Recent selection on immune response genes was identified across seven ethnicities.

COVID-19 vaccination does not significantly increase the risk of developing alopecia areata.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Some drugs may help treat both COVID-19 and radiation injury.

Stem cell therapy is promising for treating various health conditions, but more research is needed to understand its full potential and address challenges.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.

Older people with severe COVID-19, especially those with certain health conditions, are more likely to experience post-COVID syndrome.